Vivek Jain - 14 Aug 2025 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role: Chairman and CEO, Director
Signature: By: Paula Darbyshire, Attorney-in-Fact For: Vivek Jain
Issuer symbol: ICUI
Transactions as of: 14 Aug 2025
Net transactions value: +$2,474,375
Form type: 4
Filing time: 14 Aug 2025, 19:07:45 UTC
Previous filing: 12 Jun 2025
Next filing: 15 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jain Vivek	Chairman and CEO, Director	951 CALLE AMANECER, SAN CLEMENTE	By: Paula Darbyshire, Attorney-in-Fact For: Vivek Jain	14 Aug 2025	0001410442

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICUI	Common Stock	Purchase	$266,613	+2,378	+2.2%	$112.12	110,598	14 Aug 2025	Direct	F1
transaction	ICUI	Common Stock	Purchase	$2,207,761	+19,551	+18%	$112.92	130,149	14 Aug 2025	Direct	F2
holding	ICUI	Common Stock						88,698	14 Aug 2025	by Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $111.75 to $112.435 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
F2	The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $112.48 to $113.435, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

Content

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $111.75 to $112.435 inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $112.48 to $113.435, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.